Loading
Latest filing published 10 Nov 2020 for Cannara Biotech Inc. (formerly, Dunbar Capital Corp.).
No signal scores available.
Only one filing by Nicholas Sosiak is known so far (10 November 2020): a transaction, in Cannara Biotech Inc. (formerly, Dunbar Capital Corp.). That is too little to draw conclusions. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.